Home/Filings/4/0001062993-23-019059
4//SEC Filing

Frieberg Jacob B. 4

Accession 0001062993-23-019059

CIK 0001205922other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:30 PM ET

Size

39.4 KB

Accession

0001062993-23-019059

Insider Transaction Report

Form 4
Period: 2023-06-30
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-06-30$3.62/sh+2,414$8,7392,414 total
    Exercise: $5.34From: 2023-06-30Exp: 2033-06-27Common Stock (2,414 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-09-29$0.77/sh+11,291$8,69411,291 total
    Exercise: $1.13From: 2023-09-29Exp: 2033-09-26Common Stock (11,291 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $78.90Exp: 2029-03-30Common Stock (2,501 underlying)
    2,501
  • Stock Option (Right to Buy)

    Exercise: $82.80Exp: 2029-06-29Common Stock (2,385 underlying)
    2,385
  • Stock Option (Right to Buy)

    Exercise: $54.15Exp: 2030-06-28Common Stock (3,756 underlying)
    3,756
  • Stock Option (Right to Buy)

    Exercise: $31.05Exp: 2030-12-29Common Stock (6,545 underlying)
    6,545
  • Stock Option (Right to Buy)

    Exercise: $44.70Exp: 2031-03-31Common Stock (4,535 underlying)
    4,535
  • Stock Option (Right to Buy)

    Exercise: $32.25Common Stock (28,586 underlying)
    28,586
  • Stock Option (Right to Buy)

    Exercise: $42.00Exp: 2031-06-28Common Stock (4,804 underlying)
    4,804
  • Common Stock

    (indirect: By Benbow Estates, Ltd.)
    6,301
  • Stock Option (Right to Buy)

    Exercise: $116.70Common Stock (7,718 underlying)
    7,718
  • Stock Option (Right to Buy)

    Exercise: $107.55Exp: 2029-09-27Common Stock (1,856 underlying)
    1,856
  • Common Stock

    4,235
  • Common Stock

    (indirect: By Gee Eff Services Limited)
    12,870
  • Stock Option (Right to Buy)

    Exercise: $204.00Exp: 2027-09-15Common Stock (6,396 underlying)
    6,396
  • Stock Option (Right to Buy)

    Exercise: $72.75Exp: 2029-12-28Common Stock (2,737 underlying)
    2,737
  • Stock Option (Right to Buy)

    Exercise: $60.00Exp: 2030-03-29Common Stock (3,336 underlying)
    3,336
  • Stock Option (Right to Buy)

    Exercise: $59.25Common Stock (15,679 underlying)
    15,679
  • Stock Option (Right to Buy)

    Exercise: $26.70Exp: 2030-09-28Common Stock (7,626 underlying)
    7,626
  • Stock Option (Right to Buy)

    Exercise: $15.60Exp: 2031-12-29Common Stock (12,856 underlying)
    12,856
  • Stock Option (Right to Buy)

    Exercise: $32.40Exp: 2031-09-28Common Stock (6,233 underlying)
    6,233
  • Stock Option (Right to Buy)

    Exercise: $19.80Exp: 2032-03-28Common Stock (10,032 underlying)
    10,032
  • Stock Option (Right to Buy)

    Exercise: $16.80Common Stock (53,254 underlying)
    53,254
  • Stock Option (Right to Buy)

    Exercise: $16.20Exp: 2032-06-27Common Stock (12,064 underlying)
    12,064
  • Stock Option (Right to Buy)

    Exercise: $7.43Exp: 2032-09-27Common Stock (26,260 underlying)
    26,260
  • Stock Option (Right to Buy)

    Exercise: $9.68Exp: 2032-12-28Common Stock (19,852 underlying)
    19,852
  • Stock Option (Right to Buy)

    Exercise: $5.99Exp: 2033-03-28Common Stock (32,107 underlying)
    32,107
  • Stock Option (Right to Buy)

    Exercise: $6.15From: 2024-05-11Common Stock (143,848 underlying)
    143,848
Footnotes (10)
  • [F1]Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F10]Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
  • [F2]Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
  • [F3]Exercisable in full as of the date of this report.
  • [F4]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
  • [F5]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
  • [F6]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
  • [F7]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
  • [F8]This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
  • [F9]Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Issuer

VACCINEX, INC.

CIK 0001205922

Entity typeother

Related Parties

1
  • filerCIK 0001748346

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:30 PM ET
Size
39.4 KB